Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3686 Grandview Pkwy
Ste 510
Birmingham, AL 35243Phone+1 205-971-5077Fax+1 205-599-4738
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Alabama Medical CenterResidency, Internal Medicine, 2010 - 2013
- University of South Alabama College of MedicineClass of 2010
Certifications & Licensure
- AL State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsPhase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumorsRavi Kumar Paluri, Ankit Madan, Peng Li, Benjamin P Jones, Mansoor N. Saleh
Cancer Chemotherapy and Pharmacology. 2019-01-02 - 12 citationsPilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.Benjamin S. Jones, Mary S. Jerome, Deborah Miley, Bradford E. Jackson, Mollie deShazo
Lung Cancer. 2017-04-01 - 3 citationsPhase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.Ankit Madan, Benjamin S. Jones, Rodolfo Bordoni, Mansoor N. Saleh, Mary S. Jerome
Cancer Chemotherapy and Pharmacology. 2016-07-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: